Search Results
58 items found for "Paul C Hendrie"
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Oehler , Pamela S Becker , Jacob S Appelbaum , Janis L Abkowitz , Johnnie J Orozco , Siobán B Keel , Paul C Hendrie , Bart L Scott , M Cristina Ghiuzeli , Elihu H Estey , Roland B Walter Source Contribute to
- Ep 01 with Dr. Paul Insel
Paul Insel About this episode In 1975, Dr. Paul Insel was at the FASEB experimental biology meeting in Atlantic City. From that point on, Paul was hooked and has since studied receptor function in human physiology, receptor Today, Paul and his team focus on previously unrecognized receptors with the hopes to use these as novel Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles
- Ep 07 with Dr. Paul Insel
Paul Insel About this episode Dr. Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San Paul thinks broadly about science and has been actively publishing papers about his ideas on how COVID Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles
- Ep 115 with Dr. Paul J. Gasser
Paul J. Gasser About Dr. Paul J. Paul J.
- Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
However, the biological effect of natural posttranslational processing of CXCL10 at the carboxy (C)-terminus We studied CXCL10(1-73), lacking the four endmost C-terminal amino acids, which was previously identified In contrast, loss of the four endmost C-terminal residues did not affect the inhibitory properties of Conclusion: Our study shows that the C-terminal residues Lys74-Pro77 of CXCL10 are important for GAG Dominique Schols , Patrick Verschueren , Mette M Rosenkilde , Pedro Elias Marques , Sofie Struyf , Paul
- [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines
< GPCR News < GPCRs in Oncology and Immunology [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate In this work, a structural investigation on the two position of the [1,2,4]triazolo[1,5-c]pyrimidines adenosine receptor antagonists like the ethyl 2-(4-methoxyphenyl)-5-(methylamino)-[1,2,4]triazolo[1,5-c]
- GPCR Retreat Committee 2023 | Dr. GPCR Ecosystem
Paul Albert Dr. Michel Bouvier Dr. Stéphane Laporte Dr. Martin Audet Dr. Stephen Ferguson Dr.
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
Brian Kim , Marc E Rothenberg , Xin Sun , Claus Bachert , David Artis , Raza Zaheer , Yamo Deniz , Paul dermatitis , BAM8-22 , BP , Beta chain , Bovine adrenal medulla peptide 8-22 , Bullous pemphigoid , C-C
- Ep 13 with Dr. Amynah Pradhan
Paul Clarck , where she studied opioid receptors.
- Gallein, G protein βγ subunits inhibitor, suppresses the TGF-α-induced migration of hepatocellular carcinoma cells via inhibition of the c-Jun N-terminal kinase
inhibitor, suppresses the TGF-α-induced migration of hepatocellular carcinoma cells via inhibition of the c-Jun HuH7 cells through the activation of AKT, p38 mitogen-activated protein kinase (MAPK), Rho-kinase and c-Jun
- [Inhibitory effect of downregulating G protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response in human gingival fibroblasts]
GPCRs in Oncology and Immunology [Inhibitory effect of downregulating G protein-coupled receptor class C 2024 Abstract "Objective: To clarify the effect and the mechanism of G protein-coupled receptor class C
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
Schuermans , Anna Walser , Stavroula Louka , Ida Aaberg Lillethorup , Jon Våbenø , Katrine Qvortrup , Paul
- G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
current dogma is that chemoattractants G protein-coupled receptors (GPCRs) activate β phospholipase C (PLCβ) while receptor tyrosine kinases (RTKs) activate γ phospholipase C (PLCγ). chemoattractant/GPCR-mediated membrane recruitment of PLCγ2 constitutes GPCR-mediated phospholipase C receptor (GPCR) , calcium-promoted Ras inactivator (CAPRI) , chemotaxis , neutrophils , phospholipase C (PLC) , g2 phospholipase C (PLCγ2) .
- From odor to oncology: non-canonical odorant receptors in cancer
Authors Sung Jin Park , Paul L Greer , Namgyu Lee Source Contribute to the GPCR News Coming soon Become
- The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer
antibody to the human GPRC5D homodimer Published date June 19, 2024 Abstract "GPRC5D is an atypical Class C Our structural analysis reveals that the GPRC5D presents a close resemblance to the typical Class C GPCRs head-to-head homodimer arrangement and interface mainly involving TM4, setting it apart from other Class C These insights not only unveil the distinctive dimer organization of this unconventional Class C GPCR
- Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed
Authors Jillian G Baker, Erica K Sloan, Kevin Pfleger, Peter J McCormick, Cristina Salmerón, Paul A Insel
- GprC of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells for nematode hunting
The C. elegans ascaroside-sensing GPCR, SRBC66 and GPCRs of many fungi are also predicted for dual localization An SRBC64/66-GprC chimaeric protein was functional in A. flagrans, and C. elegans SRBC64/66 and DAF38 Authors Xiaodi Hu, David S Hoffmann, Mai Wang, Lars Schuhmacher, Maria C Stroe, Birgit Schreckenberger
- The β2-adrenergic receptor associates with CXCR4 multimers in human cancer cells
cancer cells Published date April 2, 2024 Abstract "While the existence and functional role of class C The C-X-C motif chemokine receptor 4 (CXCR4) is a class A GPCR that is a promising target of anticancer
- Ep 23 with Dr. Qing Fan
Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit Hendrickson at Columbia University.
- Ep 104 with Dr. Raul Gainetdinov
Raul Gainetdinov About Dr. Raul Gainetdinov Raul R. Before SPBU, Raul R. In 2018-2020, Raul R. Raul Gainetdinov on the web Saint-Petersburg State University Wikipedia Google Scholar Researchgate Google
- Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers
of CXCR2 antagonists in inflammatory diseases and cancers Published date March 15, 2023 Abstract " C-X-C
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
G-protein-coupled receptor class C group 5 member D (GPRC5D), an orphan GPCR predominantly expressed Jeong, Junhyeon Park, Geun Young Mo, Jinwoo Shin, Yunje Cho Tags GPRC5D , Multiple myeloma , class C
- Ep 144 with Dr Aurélien Rizk
During four years of postdoctoral research at ETH Zurich and the Paul Scherrer Institute in Switzerland Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr.
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
Samantha Rea , Ian Mills , Maya S Silver , Jovanni D Ahmad , Konstantin G Birukov , Anna Birukova , Henry Brem , Betty Tyler , Eli E Bar , Charles C Hong Source Contribute to the GPCR News Coming soon Become
- Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)
growth hormone-releasing hormone (GHRH), have been proposed to bind in a two-step model, where first the C-terminal Panagiotopoulos, Robin du Preez, Michail Papadourakis, Konstantinos Tsianakas, Robert P Millar, Ross C
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
receptor H1 enhances calcium signaling and cancer cell migration Published date February 1, 2023 Abstract "C-X-C
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
Additionally, molecular docking experiments demonstrated the strong binding affinity of gnetin A, gnetin C, Authors Moragot Chatatikun, Nawanwat C Pattaranggoon, Imran Sama-Ae, Onggan Ranteh, Manlika Poolpirom
- G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells
Both receptors contain PSD-95/Discs-large/ZO-1 homology (PDZ) motifs in their C-terminal tails through Deleting the GPR30 C-terminal PDZ motif (-SSAV) does not interfere with the receptor complex, indicating